Monoclonal Immunoglobulin Deposition Disease

Monoclonal Immunoglobulin Deposition Disease — Trials · CancerIndex

Clinical trials

Registered studies

148 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04847453	Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis	active not recruiting	Phase 1	24	National Cancer Institute (NCI)NIH	1	Jul 31, 2026	clinicaltrials
NCT04754945	Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis	active not recruiting	Phase 1	11	Emory UniversityOTHER	1	Jul 14, 2026	clinicaltrials